title: Low-dose bexarotene and low-dose interferon alfa-2b for adult T-cell leukemia/lymphoma associated with human T-lymphotropic virus 1.
authors.affiliation: Department of Dermatology, University of Pennsylvania Health System, Philadelphia, PA 19104, USA.
authors.forename: Stephen
authors.initials: S
authors.lastname: Richardson
authors.forename: Jeanne B
authors.initials: JB
authors.lastname: Budgin
authors.forename: Jacqueline M
authors.initials: JM
authors.lastname: Junkins-Hopkins
authors.forename: Carmela C
authors.initials: CC
authors.lastname: Vittorio
authors.forename: Jason
authors.initials: J
authors.lastname: Lee
authors.forename: Wallace T
authors.initials: WT
authors.lastname: Miller
authors.forename: Alain H
authors.initials: AH
authors.lastname: Rook
authors.forename: Ellen J
authors.initials: EJ
authors.lastname: Kim
mesh_terms: D000284:Administration, Oral; D000077610:Bexarotene; D001707:Biopsy, Needle; D001774:Blood Chemical Analysis; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D015368:Human T-lymphotropic virus 1 / Q000302:isolation & purification*; D006801:Humans; D007150:Immunohistochemistry; D007279:Injections, Subcutaneous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D018570:Risk Assessment; D013764:Tetrahydronaphthalenes / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D013764:Tetrahydronaphthalenes; D000077610:Bexarotene